Home Neoplasma 2017 Neoplasma Vol.64, No.6, p.962-970, 2017

Journal info


6 times a year.
Founded: 1954
ISSN 0028-2685
ISSN 1338-4317 (online)

Published in English

Editorial Info
Abstracted and Indexed
Submission Guidelines

Select Journal







Webshop Cart

Your Cart is currently empty.

Info: Your browser does not accept cookies. To put products into your cart and purchase them you need to enable cookies.

Neoplasma Vol.64, No.6, p.962-970, 2017

Title: Distribution of the most common polymorphisms in TYMS gene in Slavic population of central Europe
Author: A. Pastorakova, D. Chandogova, J. Chandoga, J. Luha, D. Bohmer, J. Malova, T. Braxatorisova, M. Juhosova, S. Reznakova, R. Petrovic

Abstract:

Thymidylate synthetase (TS) plays a critical role in the de novo synthesis of dTMP inside the cell. Therefore, TS is a suitable target for cytotoxic drugs such as fluoropyrimidines. Drug efficacy and toxicity depend on the intracellular level of TS, which is significantly influenced by the polymorphisms in the 5’UTR (TSER – rs45445694, TSER*3G>C – rs2853542) and 3’UTR (1494del TTAAAG – rs151264360) of TYMS gene.

Polymorphic variants of TYMS gene affect TS activity via gene expression and transcript stability. Patients who undergo fluoropyrimidine therapy may benefit from genetic testing prior to the administration of chemotherapy. At the 5’ terminus of TYMS, there is a polymorphic region represented by a variable number of 28bp long tandem repeats (2-9 tandems) with the G or C nucleotide variant (SNP G>C). The 3’end of TYMS gene may decrease the stability of mRNA in the case of 6 base deletion (1494del6, D). In our study, we have focused on testing of TYMS gene polymorphisms, determination of TYMS variant frequencies in Western Slavic population and comparison of Slovak population with other populations.
We performed identification of 5’UTR (rs45445694 – TSER*2 or TSER*3; rs2853542 – TSER*3G>C; TSER*3+ins6) and 3’UTR (rs151264360/1494del6/D) polymorphic regions of TYMS gene among 96 volunteers by PCR-RFLP and fragment analysis. Slovak frequencies of selected polymorphisms were established as follows: the frequency of TSER*2, TSER*3, TSER*3G>C, 1494del6/D and I to be 41%, 59%, 34%, 37.5% and 62.5% respectively. The high resolution of the capillary electrophoresis technique allowed among TSER*3 group identification of a subgroup of four individuals with rare 6bp insertion in 3R allele, id est 2.1% TSER*3+ins6 allele frequency. In our study, we have revealed individuals with rare G>C substitution in the first 28bp tandem repeat of TSER*2 promoter enhancer region (rs183205964) as well, the overall frequency of this polymorphic allele in Slovak population was 2.1%.
Our results proved that Slovak population is in Hardy-Weinberg equilibrium and proportion of TYMS polymorphisms is in accordance with other published data.



Keywords: fluoropyrimidines, thymidylate synthetase, pharmacogenetics, polymorphism, Slovak
Published online: 14-Nov-2017
Year: 2017, Volume: 64, Issue: 6 Page From: 962, Page To: 970
doi:10.4149/neo_2017_620
Price: 21.60 €






© AEPress s.r.o
Copyright notice: For any permission to reproduce, archive or otherwise use the documents in the ELiS, please contact AEP.